top of page
Wegovy’s $499 ‘Price Cut’: The Hype, The Reality, and The Part Everyone’s Ignoring
Novo Nordisk just announced Wegovy for $499/month on its direct-to-consumer platform—but is this price cut really a game-changer?
Mar 112 min read
PoundsPunch Periodical 2025.02: FDA Cracks Down on Compounded Semaglutide, Eli Lilly Slashes Zepbound Prices, and Insurance Struggles Continue
FDA Cracks Down on Compounded Semaglutide, Eli Lilly Slashes Zepbound Prices, and Insurance Struggles Continue
Feb 282 min read
PoundsPunch Periodical 2025.01: Medicare Moves to Negotiate Ozempic Prices
Explore Medicare's groundbreaking decision to negotiate Ozempic pricing in PoundsPunch Periodical 2025.01.
Jan 312 min read
PoundsPunch Periodical November 2024: Policy Showdowns, Counterfeit Crises, and Industry Disruptions in the Weight-Loss Drug Market
Biden’s Weight-Loss Drug Proposal Faces Trump-Era Challenges, Ireland’s Crackdown on Counterfeits, and China’s Next-Gen GLP-1 Innovations
Nov 30, 20247 min read
FTC Sues Prescription Drug Middlemen for Inflating Insulin Prices—What Does that Mean?
Caremark, Express Scripts, and OptumRx Face Allegations of Rigging the Rebate System
Nov 19, 20244 min read
Breaking Down the Costs of Ozempic, Wegovy, Mounjaro and Zepbound
A Closer Look at Cost Structure of Ozempic and Other New Weight Loss Drugs.
Feb 9, 20244 min read
bottom of page